Another study also suggested anti-PD-1 resistant NSCLC harbored higher expression levels of TIM-3, LAG-3, and CTLA-4 on CD4+ and CD8+ T cells in, but only TIM-3 was significantly increased, suggesting the TIM-3 upregulation surrogate mechanism (53). The gene discussed is LAG3; the disease is non-small cell lung carcinoma.